- Home
- PRPL vs GNLX Comparison
PRPL vs GNLX Comparison
Compare PRPL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRPL | GNLX |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.8M | 202.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | PRPL | GNLX |
|---|---|---|
| Price | $0.78 | $4.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $1.00 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 291.0K | 177.7K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $457,012,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.56 | $1.99 |
| 52 Week High | $1.29 | $8.54 |
Technical Indicators
Market Signals| Indicator | PRPL | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 33.52 |
| Support Level | $0.73 | $4.37 |
| Resistance Level | $0.87 | $4.75 |
| Average True Range (ATR) | 0.06 | 0.41 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 43.46 | 5.82 |
Price Performance
Historical ComparisonAbout PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.